Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 13Stomach Neoplasms 7Pancreatic Neoplasms 7Colonic Neoplasms 4Rectal Neoplasms 3Pain, Postoperative 3Neurotoxicity Syndromes 3Lung Neoplasms 2Gastrointestinal Neoplasms 2Esophageal Neoplasms 2Carcinoma, Hepatocellular 2Breast Neoplasms 2Uterine Cervical Neoplasms 1Surgical Wound Infection 1Stomatitis 1Sigmoid Neoplasms 1Recurrence 1Ovarian Neoplasms 1Neutropenia 1Neoplasms 1Melanoma 1Lung Injury 1Ileus 1Hidrocystoma 1Head and Neck Neoplasms 1Gastrointestinal Stromal Tumors 1Febrile Neutropenia 1Fatigue 1Esophageal Atresia 1Endometrial Neoplasms 1

Interventions

Sodium Chloride 1Amiodarone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Atrial Fibrillation × Sodium Chloride × Gastrointestinal × Clear all
NCT06067438 2026-05-22

Amiodarone for the Prevention of Atrial Fibrillation After Minimally Invasive Esophagectomy in Patients With Esophageal Cancer

OHSU Knight Cancer Institute

Phase 2 Recruiting
90 enrolled
Gastrointestinal

Atrial Fibrillation, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡